Bristol-Myers Squibb (BMY)
NYSE: BMY
· Real-Time Price · USD
44.90
-0.08 (-0.18%)
At close: Sep 23, 2025, 3:59 PM
44.91
0.02%
After-hours: Sep 23, 2025, 07:59 PM EDT
-0.18% (1D)
| Bid | 44.82 |
| Market Cap | 91.39B |
| Revenue (ttm) | 47.7B |
| Net Income (ttm) | 5.05B |
| EPS (ttm) | 2.49 |
| PE Ratio (ttm) | 18.03 |
| Forward PE | 7.46 |
| Analyst | Hold |
| Dividends | $3.08 |
| Ask | 44.93 |
| Volume | 11,180,789 |
| Avg. Volume (20D) | 13,011,582.7 |
| Open | 44.92 |
| Previous Close | 44.98 |
| Day's Range | 44.71 - 45.59 |
| 52-Week Range | 42.96 - 63.33 |
| Beta | 0.36 |
| Ex-Dividend Date | Oct 3, 2025 |
Analyst Forecast
According to 0 analyst ratings, the average rating for BMY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsBristol-Myers Squibb is scheduled to release its earnings on
Oct 30, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-5.81%
BMY stock has given up its prior gain. Bristol-Mye...
Unlock content with
Pro Subscription
1 month ago
-5.81%
Bristol-Myers Squibb shares are trading higher after the company reported a Q2 sales beat and raised its FY25 sales guidance above estimates.
